Sign in

CIK 0001727196

  • Non-accelerated filer

Scholar Rock Holding Corp

Sign in to watch
Ticker
SRRK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823750435
Phone
+1 857-259-3860
Business address
301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$11,999,922
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. AKKARAJU SRINIVAS +$12.0M Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2021-02-01 Myles Edward H Chief Financial Officer Grant or award +24,150 24,150
2021-02-01 Myles Edward H Chief Financial Officer Grant or award · Stock Option (Right to Buy) +80,500 346,301
2021-02-01 Kingsley Stuart A President and CEO Grant or award +42,000 42,000
2021-02-01 Kingsley Stuart A President and CEO Grant or award · Stock Option (Right to Buy) +140,000 590,000
2021-01-27 Carven Gregory John Head of Research Sale −5,400 $55.87 $302K 46,434
2021-01-27 Carven Gregory John Head of Research Sale −12,139 $56.72 $689K 34,295
2021-01-27 Carven Gregory John Head of Research Sale −1,561 $57.79 $90K 32,734
2021-01-27 Carven Gregory John Head of Research Exercise or conversion +6,619 $15.11 $100K 82,734
2021-01-27 Carven Gregory John Head of Research Sale −5,400 $55.87 $302K 40,560
2021-01-27 Carven Gregory John Head of Research Sale −12,139 $56.72 $689K 28,421
2021-01-27 Carven Gregory John Head of Research Sale −1,561 $57.79 $90K 26,860
2021-01-27 Carven Gregory John Head of Research Exercise or conversion · Stock Option (Right to Buy) −6,619 16,316
2021-01-26 Carven Gregory John Head of Research Sale −2,543 $60.65 $154K 52,898
2021-01-26 Carven Gregory John Head of Research Sale −1,064 $61.52 $65K 51,834
2021-01-26 Gilman Michael Director Exercise or conversion +2,188 $5.77 $13K 46,147
2021-01-26 Gilman Michael Director Exercise or conversion +1,313 $5.77 $8K 47,460
2021-01-26 Gilman Michael Director Sale −483 $57.99 $28K 46,977
2021-01-26 Gilman Michael Director Sale −1,500 $59.02 $89K 45,477
2021-01-26 Gilman Michael Director Sale −1,518 $59.90 $91K 43,959
2021-01-26 Gilman Michael Director Exercise or conversion · Stock Option (Right to Buy) −2,188 1,314

Page 25 of 33 · 642 trades